Cargando…

The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

BACKGROUND: Physical Examination (PE) and breast MRI are two of the currentmethods which have usually used in diagnosis of primary breast cancer. Their accuracy in detection of: either complete response or presence of residual tumor, however, has not yet been established in patients who have been re...

Descripción completa

Detalles Bibliográficos
Autores principales: Abedi, Mahboobeh, Farrokh, Donya, Shandiz Homaei, Fatemeh, Joulaee, Azadeh, Anbiaee, Robab, Zandi, Behrooz, Gity, Masoumeh, Sayah, Hamid Reza, Abedi, Mohammad Sadegh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Research Center, Shahid Beheshti University of Medical Sciences 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142902/
https://www.ncbi.nlm.nih.gov/pubmed/25250107
_version_ 1782331830558523392
author Abedi, Mahboobeh
Farrokh, Donya
Shandiz Homaei, Fatemeh
Joulaee, Azadeh
Anbiaee, Robab
Zandi, Behrooz
Gity, Masoumeh
Sayah, Hamid Reza
Abedi, Mohammad Sadegh
author_facet Abedi, Mahboobeh
Farrokh, Donya
Shandiz Homaei, Fatemeh
Joulaee, Azadeh
Anbiaee, Robab
Zandi, Behrooz
Gity, Masoumeh
Sayah, Hamid Reza
Abedi, Mohammad Sadegh
author_sort Abedi, Mahboobeh
collection PubMed
description BACKGROUND: Physical Examination (PE) and breast MRI are two of the currentmethods which have usually used in diagnosis of primary breast cancer. Their accuracy in detection of: either complete response or presence of residual tumor, however, has not yet been established in patients who have been received Neoadjuvant Chemotherapy (NAC).The purpose of this study was to evaluate the diagnostic accuracy of breast MRI in assessment of residual neoplastic tissue after NAC in patients with Locally Advanced Breast Cancer (LABC). METHODS: Twenty patients with LABC have undergone contrast-enhanced MRI before and after the NAC. Considering histology as the gold standard, the tumor sizes in MRI and PE have compared with the histology results. We have calculated for all below: the accuracy, sensitivity, specificity, Positive Predictive Value (PPV) and Negative Predictive Value (NPV) for each of MRI and physical examination, as well as Pearson's correlation coefficients between the results of MRI and PE, and their histology results. RESULTS: We have found an accuracy of 85% for MRI with a sensitivity of 100%, a specificity of 50%, a PPV of 83.3%, and an NPV of 100%. In addition, theaccuracy for PE was 70% with a sensitivity of 71.4%, a specificity of 66.6%, a PPV of 83.3%, and an NPV of 50%. In this study, the calculated Pearson's correlation coefficient for MRI and histology was 0.817 (p<0.0001) versus 0.26 (p=0.26) for correlation between PE and histology. CONCLUSION: MRI has higher sensitivity but less specificity than PE for detection of residual tumor after NAC in locally advanced breast carcinoma. Also, the tumor size that has measured by MRI had highly correlation with the histology.
format Online
Article
Text
id pubmed-4142902
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Cancer Research Center, Shahid Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-41429022014-09-23 The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Abedi, Mahboobeh Farrokh, Donya Shandiz Homaei, Fatemeh Joulaee, Azadeh Anbiaee, Robab Zandi, Behrooz Gity, Masoumeh Sayah, Hamid Reza Abedi, Mohammad Sadegh Iran J Cancer Prev Original Article BACKGROUND: Physical Examination (PE) and breast MRI are two of the currentmethods which have usually used in diagnosis of primary breast cancer. Their accuracy in detection of: either complete response or presence of residual tumor, however, has not yet been established in patients who have been received Neoadjuvant Chemotherapy (NAC).The purpose of this study was to evaluate the diagnostic accuracy of breast MRI in assessment of residual neoplastic tissue after NAC in patients with Locally Advanced Breast Cancer (LABC). METHODS: Twenty patients with LABC have undergone contrast-enhanced MRI before and after the NAC. Considering histology as the gold standard, the tumor sizes in MRI and PE have compared with the histology results. We have calculated for all below: the accuracy, sensitivity, specificity, Positive Predictive Value (PPV) and Negative Predictive Value (NPV) for each of MRI and physical examination, as well as Pearson's correlation coefficients between the results of MRI and PE, and their histology results. RESULTS: We have found an accuracy of 85% for MRI with a sensitivity of 100%, a specificity of 50%, a PPV of 83.3%, and an NPV of 100%. In addition, theaccuracy for PE was 70% with a sensitivity of 71.4%, a specificity of 66.6%, a PPV of 83.3%, and an NPV of 50%. In this study, the calculated Pearson's correlation coefficient for MRI and histology was 0.817 (p<0.0001) versus 0.26 (p=0.26) for correlation between PE and histology. CONCLUSION: MRI has higher sensitivity but less specificity than PE for detection of residual tumor after NAC in locally advanced breast carcinoma. Also, the tumor size that has measured by MRI had highly correlation with the histology. Cancer Research Center, Shahid Beheshti University of Medical Sciences 2013 /pmc/articles/PMC4142902/ /pubmed/25250107 Text en © 2014 Cancer Research Center, Shahid Beheshti University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Abedi, Mahboobeh
Farrokh, Donya
Shandiz Homaei, Fatemeh
Joulaee, Azadeh
Anbiaee, Robab
Zandi, Behrooz
Gity, Masoumeh
Sayah, Hamid Reza
Abedi, Mohammad Sadegh
The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
title The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
title_full The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
title_fullStr The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
title_full_unstemmed The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
title_short The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
title_sort validity of mri in evaluation of tumor response to neoadjuvant chemotherapy in locally advanced breast cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142902/
https://www.ncbi.nlm.nih.gov/pubmed/25250107
work_keys_str_mv AT abedimahboobeh thevalidityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT farrokhdonya thevalidityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT shandizhomaeifatemeh thevalidityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT joulaeeazadeh thevalidityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT anbiaeerobab thevalidityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT zandibehrooz thevalidityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT gitymasoumeh thevalidityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT sayahhamidreza thevalidityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT abedimohammadsadegh thevalidityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT abedimahboobeh validityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT farrokhdonya validityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT shandizhomaeifatemeh validityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT joulaeeazadeh validityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT anbiaeerobab validityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT zandibehrooz validityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT gitymasoumeh validityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT sayahhamidreza validityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer
AT abedimohammadsadegh validityofmriinevaluationoftumorresponsetoneoadjuvantchemotherapyinlocallyadvancedbreastcancer